Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
“By identifying off-targets TPP can be used to study possible side effects of candidate drug compounds [150].”
BackgroundIdentification of bioactive metabolites using activity metabolomics
Rinschen, M. M., Ivanisevic, J., Giera, M., & Siuzdak, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0108-4 · Cited by 1,008
Kinase inhibitors: the road ahead
Ferguson, F. M., & Gray, N. S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.21 · Cited by 1,009
Luo, Y., Zhao, X., Zhou, J., Yang, J., Zhang, Y., Kuang, W., Peng, J., Chen, L., & Zeng, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00680-8 · Cited by 916
The target landscape of clinical kinase drugs
Klaeger, S., Heinzlmeir, S., Wilhelm, M., Polzer, H., Vick, B., Koenig, P.-A., Reinecke, M., Ruprecht, B., Petzoldt, S., Meng, C., et al. (2017) · Science · doi:10.1126/science.aan4368 · Cited by 854
“Recent reports have shown that KIs can bind the enzyme FECH and that inhibition of FECH is the mechanism by which the clinically observed photosensitivity of vemurafenib patients can be rationalized (38, 39).”
BackgroundSelf-citationControl of protein stability by post-translational modifications
Lee, J. M., Hammarén, H. M., Savitski, M. M., & Baek, S. H. (2023) · Nature Communications · doi:10.1038/s41467-023-35795-8 · Cited by 796
Self-citationFranken, H., Mathieson, T., Childs, D., Sweetman, G. M. A., Werner, T., Tögel, I., Doce, C., Gade, S., Bantscheff, M., Drewes, G., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.101 · Cited by 659
Self-citationA Map of Protein-Metabolite Interactions Reveals Principles of Chemical Communication
Piazza, I., Kochanowski, K., Cappelletti, V., Fuhrer, T., Noor, E., Sauer, U., & Picotti, P. (2018) · Cell · doi:10.1016/j.cell.2017.12.006 · Cited by 556
Lanthanides in Luminescent Thermometry
Brites, C. D. S., Millán, A., & Carlos, L. D. (2016) · Handbook on the Physics and Chemistry of Rare Earths · doi:10.1016/bs.hpcre.2016.03.005 · Cited by 536
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
Smith, B. E., Wang, S. L., Jaime-Figueroa, S., Harbin, A., Wang, J., Hamman, B. D., & Crews, C. M. (2019) · Nature Communications · doi:10.1038/s41467-018-08027-7 · Cited by 517
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Proschak, E., Stark, H., & Merk, D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00760 · Cited by 498
Bruderer, R., Bernhardt, O. M., Gandhi, T., Xuan, Y., Sondermann, J., Schmidt, M., Gomez-Varela, D., & Reiter, L. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000314 · Cited by 492
The functional landscape of the human phosphoproteome
Ochoa, D., Jarnuczak, A. F., Viéitez, C., Gehre, M., Soucheray, M., Mateus, A., Kleefeldt, A. A., Hill, A., Garcia-Alonso, L., Stein, F., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0344-3 · Cited by 491
Self-citationLi, J., Van Vranken, J. G., Pontano Vaites, L., Schweppe, D. K., Huttlin, E. L., Etienne, C., Nandhikonda, P., Viner, R., Robitaille, A. M., Thompson, A. H., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0781-4 · Cited by 449
A Scalable Approach for Protein False Discovery Rate Estimation in Large Proteomic Data Sets
Savitski, M. M., Wilhelm, M., Hahne, H., Kuster, B., & Bantscheff, M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.046995 · Cited by 445
Self-citationLigand and Target Discovery by Fragment-Based Screening in Human Cells
Parker, C. G., Galmozzi, A., Wang, Y., Correia, B. E., Sasaki, K., Joslyn, C. M., Kim, A. S., Cavallaro, C. L., Lawrence, R. M., Johnson, S. R., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.029 · Cited by 439
A Novel LC System Embeds Analytes in Pre-formed Gradients for Rapid, Ultra-robust Proteomics
Bache, N., Geyer, P. E., Bekker-Jensen, D. B., Hoerning, O., Falkenby, L., Treit, P. V., Doll, S., Paron, I., Müller, J. B., Meier, F., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir118.000853 · Cited by 411
“There are several proteomics strategies that produce many fractions, such as thermal shift assays (31) or organellar proteomics (32), and our approach opens up for strategies to rapidly and robustly measure these.”
BackgroundCell-wide analysis of protein thermal unfolding reveals determinants of thermostability
Leuenberger, P., Ganscha, S., Kahraman, A., Cappelletti, V., Boersema, P. J., von Mering, C., Claassen, M., & Picotti, P. (2017) · Science · doi:10.1126/science.aai7825 · Cited by 411
“CETSA is based on the measurement of protein precipitation in cell lysates upon an increase in temperature.”
MethodResultInfluentialMultidimensional proteomics for cell biology
Larance, M., & Lamond, A. I. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3970 · Cited by 411
Chemical proteomics approaches for identifying the cellular targets of natural products
Wright, M. H., & Sieber, S. A. (2016) · Natural Product Reports · doi:10.1039/c6np00001k · Cited by 391
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
Click Chemistry in Proteomic Investigations
Parker, C. G., & Pratt, M. R. (2020) · Cell · doi:10.1016/j.cell.2020.01.025 · Cited by 380
“Recent advances in “label-free” proteomic methods, such as thermal proteome profiling (TPP) and drug affinity responsive target stability (DARTS), represent powerful complementary strategies to map small molecule-protein interactions, bypassing the requirement of enrichment handles such as click functional groups (Lom…”
Systematic analysis of protein turnover in primary cells
Mathieson, T., Franken, H., Kosinski, J., Kurzawa, N., Zinn, N., Sweetman, G., Poeckel, D., Ratnu, V. S., Schramm, M., Becher, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03106-1 · Cited by 379
Self-citationMega-scale experimental analysis of protein folding stability in biology and design
Tsuboyama, K., Dauparas, J., Chen, J., Laine, E., Mohseni Behbahani, Y., Weinstein, J. J., Mangan, N. M., Ovchinnikov, S., & Rocklin, G. J. (2023) · Nature · doi:10.1038/s41586-023-06328-6 · Cited by 350
“Compared with mass spectrometry-based high-throughput stability assays 16,17 , cDNA display proteolysis achieves a 100-fold larger scale and can easily be applied to study mutational libraries that pose difficulties for proteomics.”
BackgroundA Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance
Martin, J. K., Sheehan, J. P., Bratton, B. P., Moore, G. M., Mateus, A., Li, S. H.-J., Kim, H., Rabinowitz, J. D., Typas, A., Savitski, M. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.005 · Cited by 356
Self-citationThe emerging role of mass spectrometry-based proteomics in drug discovery
Meissner, F., Geddes-McAlister, J., Mann, M., & Bantscheff, M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00409-3 · Cited by 341
Self-citationIlluminating the dark phosphoproteome
Needham, E. J., Parker, B. L., Burykin, T., James, D. E., & Humphrey, S. J. (2019) · Science Signaling · doi:10.1126/scisignal.aau8645 · Cited by 334
“This technique has been used to globally investigate drug-binding targets (129), protein- protein interactions (130), and inter- and intraspecies thermostability (131).”
MethodProteomic and interactomic insights into the molecular basis of cell functional diversity
Bludau, I., & Aebersold, R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0231-2 · Cited by 297
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins
Reinhard, F. B. M., Eberhard, D., Werner, T., Franken, H., Childs, D., Doce, C., Savitski, M. F., Huber, W., Bantscheff, M., Savitski, M. M., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3652 · Cited by 315
Self-citationMartinez Molina, D., & Nordlund, P. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103715 · Cited by 306
Self-citationA Review on Quantitative Multiplexed Proteomics
Pappireddi, N., Martin, L., & Wühr, M. (2019) · ChemBioChem · doi:10.1002/cbic.201800650 · Cited by 299
Schopper, S., Kahraman, A., Leuenberger, P., Feng, Y., Piazza, I., Müller, O., Boersema, P. J., & Picotti, P. (2017) · Nature Protocols · doi:10.1038/nprot.2017.100 · Cited by 288
Proteome Integral Solubility Alteration: A High-Throughput Proteomics Assay for Target Deconvolution
Gaetani, M., Sabatier, P., Saei, A. A., Beusch, C. M., Yang, Z., Lundström, S. L., & Zubarev, R. A. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00500 · Cited by 287
Vasta, J. D., Corona, C. R., Wilkinson, J., Zimprich, C. A., Hartnett, J. R., Ingold, M. R., Zimmerman, K., Machleidt, T., Kirkland, T. A., Huwiler, K. G., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.10.010 · Cited by 268
“CETSA is also reportedly prone to a number of noteworthy false-negative results for multikinase inhibitors, limiting its utility in the context of broad kinome profiling (Savitski et al., 2014).”
BackgroundInfluentialTarget engagement and drug residence time can be observed in living cells with BRET
Robers, M. B., Dart, M. L., Woodroofe, C. C., Zimprich, C. A., Kirkland, T. A., Machleidt, T., Kupcho, K. R., Levin, S., Hartnett, J. R., Zimmerman, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms10091 · Cited by 274
Meltome atlas—thermal proteome stability across the tree of life
Jarzab, A., Kurzawa, N., Hopf, T., Moerch, M., Zecha, J., Leijten, N., Bian, Y., Musiol, E., Maschberger, M., Stoehr, G., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0801-4 · Cited by 281
Self-citationThermal proteome profiling for interrogating protein interactions
Mateus, A., Kurzawa, N., Becher, I., Sridharan, S., Helm, D., Stein, F., Typas, A., & Savitski, M. M. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199232 · Cited by 258
“Using this approach, it has been possible to deconvolute drug targets (Savitski et al , 2014, 2018; Huber et al , 2015; Reinhard et al , 2015; Becher et al , 2016; Mateus et al , 2016, 2018; Kitagawa et al , 2017; Azimi et al , 2018; Hu et al , 2019) and enzyme substrates (preprint: Saei et al ,…”
InfluentialSelf-citationChen, X., Wang, Y., Ma, N., Tian, J., Shao, Y., Zhu, B., Wong, Y. K., Liang, Z., Zou, C., & Wang, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0186-y · Cited by 263
“To overcome the challenges of low sensitivity and throughput in CETSA, TPP was developed.(100) It is derived from CETSA but also allows the identification of off-targets and biomarkers.”
BackgroundProteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP
Sridharan, S., Kurzawa, N., Werner, T., Günthner, I., Helm, D., Huber, W., Bantscheff, M., & Savitski, M. M. (2019) · Nature Communications · doi:10.1038/s41467-019-09107-y · Cited by 267
Self-citationThermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat
Becher, I., Werner, T., Doce, C., Zaal, E. A., Tögel, I., Khan, C. A., Rueger, A., Muelbaier, M., Salzer, E., Berkers, C. R., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2185 · Cited by 251
Self-citationJost, M., Chen, Y., Gilbert, L. A., Horlbeck, M. A., Krenning, L., Menchon, G., Rai, A., Cho, M. Y., Stern, J. J., Prota, A. E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.012 · Cited by 247
“For example, approaches based on prote-ome-wide profiling of drug-induced protein stabilization (Savitski et al., 2014) or drug derivatization and affinity pull-down (Rix and Superti-Furga, 2009) report on binding but do not inherently reveal function and may fail for compounds that bind with low…”
Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells
Tan, C. S. H., Go, K. D., Bisteau, X., Dai, L., Yong, C. H., Prabhu, N., Ozturk, M. B., Lim, Y. T., Sreekumar, L., Lengqvist, J., et al. (2018) · Science · doi:10.1126/science.aan0346 · Cited by 224
Self-citationA Global Map of Lipid-Binding Proteins and Their Ligandability in Cells
Niphakis, M. J., Lum, K. M., Cognetta, A. B., Correia, B. E., Ichu, T.-A., Olucha, J., Brown, S. J., Kundu, S., Piscitelli, F., Rosen, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.045 · Cited by 239
“Some proteins interacted strongly withmultiple drugs, such as ferrochelatase (FECH), which was recently found to bind kinase inhibitors in cells using thermal proteome profiling (Savitski et al., 2014).”
Pervasive Protein Thermal Stability Variation during the Cell Cycle
Becher, I., Andrés-Pons, A., Romanov, N., Stein, F., Schramm, M., Baudin, F., Helm, D., Kurzawa, N., Mateus, A., Mackmull, M.-T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.053 · Cited by 230
“Since substrate binding increases the stability of enzymes (Savitski et al., 2014), our data can serve as a proxy for enzyme activity.”
BackgroundMethodInfluentialSelf-citationSchmidt, T., Samaras, P., Frejno, M., Gessulat, S., Barnert, M., Kienegger, H., Krcmar, H., Schlegl, J., Ehrlich, H.-C., Aiche, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1029 · Cited by 221
“The ‘Biochemical assay’ tab (Supplementary Figure S3) provides dedicated views for such data and currently offers the exploration of Kinobeads (20,21) data, a competition binding assay used to decipher kinase:small molecule interactions, and two formats of cellular thermal shift data (22).”
MethodThe diverse and expanding role of mass spectrometry in structural and molecular biology
Lössl, P., van de Waterbeemd, M., & Heck, A. J. (2016) · The EMBO Journal · doi:10.15252/embj.201694818 · Cited by 222
“Complementary to limited proteolysis, structural aspects of proteins can also be probed by the proteome-wide monitoring of thermal protein denaturation (Savitski et al , 2014; Reinhard et al , 2015).”
Dziekan, J. M., Yu, H., Chen, D., Dai, L., Wirjanata, G., Larsson, A., Prabhu, N., Sobota, R. M., Bozdech, Z., & Nordlund, P. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau3174 · Cited by 218
“Furthermore, the predominantly insoluble nature of membrane proteins (57), or their presence in soluble lipid bilayer particles generated during cell lysis, results in their limited propensity for observable thermal shifts in the current version of the CETSA protocol (21).”
BackgroundResultSelf-citationMultiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Savitski, M. M., Zinn, N., Faelth-Savitski, M., Poeckel, D., Gade, S., Becher, I., Muelbaier, M., Wagner, A. J., Strohmer, K., Werner, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.030 · Cited by 218
Self-citationLactate regulates cell cycle by remodelling the anaphase promoting complex
Liu, W., Wang, Y., Bozi, L. H. M., Fischer, P. D., Jedrychowski, M. P., Xiao, H., Wu, T., Darabedian, N., He, X., Mills, E. L., et al. (2023) · Nature · doi:10.1038/s41586-023-05939-3 · Cited by 216
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
Saraon, P., Pathmanathan, S., Snider, J., Lyakisheva, A., Wong, V., & Stagljar, I. (2021) · Oncogene · doi:10.1038/s41388-021-01841-2 · Cited by 205
“, detected with antibodies or via mass spectrometry [55, 56]) or artificially tagged targets (e.”
BackgroundProteome-wide drug and metabolite interaction mapping by thermal-stability profiling
Huber, K. V. M., Olek, K. M., Müller, A. C., Tan, C. S. H., Bennett, K. L., Colinge, J., & Superti-Furga, G. (2015) · Nature Methods · doi:10.1038/nmeth.3590 · Cited by 210
Mass spectrometry‐based protein–protein interaction networks for the study of human diseases
Richards, A. L., Eckhardt, M., & Krogan, N. J. (2021) · Molecular Systems Biology · doi:10.15252/msb.20188792 · Cited by 201
“On the other hand, Nordlund et al adapted their cellular thermal shift assay (Savitski et al, 2014) to develop thermal proximity coaggregation (TPCA), a high-throughput method to monitor PPIs across the proteome (Dai et al, 2018).”
MethodProThermDB: thermodynamic database for proteins and mutants revisited after 15 years
Nikam, R., Kulandaisamy, A., Harini, K., Sharma, D., & Gromiha, M. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1035 · Cited by 197
Tu, Y., Tan, L., Tao, H., Li, Y., & Liu, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154862 · Cited by 190
Thermal proteome profiling in bacteria: probing protein state in vivo
Mateus, A., Bobonis, J., Kurzawa, N., Stein, F., Helm, D., Hevler, J., Typas, A., & Savitski, M. M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20188242 · Cited by 189
“…physiological changes in protein state: protein – metabolite interactions, post-translational modifications, protein – protein interactions, protein – DNA interactions, and chaperone – client interactions (Savitski et al , 2014, 2018; Reinhard et al , 2015; Becher et al , 2018; Tan et al , 2018).”
InfluentialSelf-citationProteomicsDB: a multi-omics and multi-organism resource for life science research
Samaras, P., Schmidt, T., Frejno, M., Gessulat, S., Reinecke, M., Jarzab, A., Zecha, J., Mergner, J., Giansanti, P., Ehrlich, H.-C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz974 · Cited by 185
“We further increased the amount of protein property information that is stored in ProteomicsDB, such as 13 000 melting points of proteins obtained by thermal proteome profiling (17).”
BackgroundAkhoundova, D., & Rubin, M. A. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.011 · Cited by 182
The Small Non-coding Vault RNA1-1 Acts as a Riboregulator of Autophagy
Horos, R., Büscher, M., Kleinendorst, R., Alleaume, A.-M., Tarafder, A. K., Schwarzl, T., Dziuba, D., Tischer, C., Zielonka, E. M., Adak, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.030 · Cited by 181
Piazza, I., Beaton, N., Bruderer, R., Knobloch, T., Barbisan, C., Chandat, L., Sudau, A., Siepe, I., Rinner, O., de Souza, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18071-x · Cited by 181
Identifying drug targets in tissues and whole blood with thermal-shift profiling
Perrin, J., Werner, T., Kurzawa, N., Rutkowska, A., Childs, D. D., Kalxdorf, M., Poeckel, D., Stonehouse, E., Strohmer, K., Heller, B., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0388-4 · Cited by 178
Self-citationDynamic 3D proteomes reveal protein functional alterations at high resolution in situ
Cappelletti, V., Hauser, T., Piazza, I., Pepelnjak, M., Malinovska, L., Fuhrer, T., Li, Y., Dörig, C., Boersema, P., Gillet, L., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.021 · Cited by 176
“LiP-MS and other structural proteomics approaches have been used in numerous protein structural studies (Aebersold and Mann, 2016; Huber et al., 2015; Leuenberger et al., 2017; Liu et al., 2018; Piazza et al., 2018; Savitski et al., 2014).”
New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome
Wilson, L. J., Linley, A., Hammond, D. E., Hood, F. E., Coulson, J. M., MacEwan, D. J., Ross, S. J., Slupsky, J. R., Smith, P. D., Eyers, P. A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2291 · Cited by 172
Thinking Outside the Box—Novel Antibacterials To Tackle the Resistance Crisis
Lakemeyer, M., Zhao, W., Mandl, F. A., Hammann, P., & Sieber, S. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804971 · Cited by 169
Modulation of Protein-Interaction States through the Cell Cycle
Dai, L., Zhao, T., Bisteau, X., Sun, W., Prabhu, N., Lim, Y. T., Sobota, R. M., Kaldis, P., & Nordlund, P. (2018) · Cell · doi:10.1016/j.cell.2018.03.065 · Cited by 168
“By coupling CETSA with mass spectrometry (MS-CETSA, also called ‘‘thermal proteome profiling’’), proteome-wide interactions can be studied (Savitski et al., 2014).”
Self-citationCharacterizing Protein–Protein Interactions Using Mass Spectrometry: Challenges and Opportunities
Smits, A. H., & Vermeulen, M. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.02.014 · Cited by 167
“The methodology is suitable to study membrane proteins [42,43] and can be performed on intact cells [41,44].”
BackgroundIdentifying compound efficacy targets in phenotypic drug discovery
Schirle, M., & Jenkins, J. L. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.001 · Cited by 164
Piñol, R., Brites, C. D. S., Bustamante, R., Martínez, A., Silva, N. J. O., Murillo, J. L., Cases, R., Carrey, J., Estepa, C., Sosa, C., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b00059 · Cited by 165
“This opens intriguing possibilities in studies of the heat flowat the nanoscale, including thermal capacitance and conductivity across nanostructured media,(36) as for instance detailed studies in cellular thermal processes.(37,38) In addition, we have established the local temperature mapping near”
BackgroundAlmqvist, H., Axelsson, H., Jafari, R., Dan, C., Mateus, A., Haraldsson, M., Larsson, A., Molina, D. M., Artursson, P., Lundbäck, T., et al. (2016) · Nature Communications · doi:10.1038/ncomms11040 · Cited by 160
Self-citationRecent advances in proteomics and metabolomics in plants
Yan, S., Bhawal, R. P., Yin, Z., Thannhauser, T. W., & Zhang, S. (2022) · Molecular Horticulture · doi:10.1186/s43897-022-00038-9 · Cited by 187
“This TPP was initially developed for drug discovery in screening of the targeted proteins by the known ligands (drugs) under a more physiologically relevant environment such as intact live cells level (Savitski et al. 2014).”
BackgroundIn silico polypharmacology of natural products
Fang, J., Liu, C., Wang, Q., Lin, P., & Cheng, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx045 · Cited by 196
Mateus, A., Määttä, T. A., & Savitski, M. M. (2016) · Proteome Science · doi:10.1186/s12953-017-0122-4 · Cited by 165
“, 49 of the 66 kinases that staurosporine inhibits, and that could be detected in K562 cell extracts, showed a reproducible shift in Tm of more than 1 °C [15].”
BackgroundMethodInfluentialSelf-citationRecent advances in identifying protein targets in drug discovery
Ha, J., Park, H., Park, J., & Park, S. B. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.12.001 · Cited by 165
Chang, J., Kim, Y., & Kwon, H. J. (2016) · Natural Product Reports · doi:10.1039/c5np00107b · Cited by 153
Xi, X., Liu, N., Wang, Q., Chu, Y., Yin, Z., Ding, Y., & Lu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1986-2 · Cited by 147
Brehmer, D., Beke, L., Wu, T., Millar, H. J., Moy, C., Sun, W., Mannens, G., Pande, V., Boeckx, A., van Heerde, E., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0367 · Cited by 150
“These are unlikely to be PRMT5 binders as they are frequently identified as false positive hits in chemical proteomic analyses (28, 29).”
BackgroundChristopher, J. A., Stadler, C., Martin, C. E., Morgenstern, M., Pan, Y., Betsinger, C. N., Rattray, D., Mahdessian, D., Gingras, A., Warscheid, B., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00029-y · Cited by 155
Malinovska, L., Cappelletti, V., Kohler, D., Piazza, I., Tsai, T., Pepelnjak, M., Stalder, P., Dörig, C., Sesterhenn, F., Elsässer, F., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00771-x · Cited by 137
Validation and development of MTH1 inhibitors for treatment of cancer
Berglund, U. W., Sanjiv, K., Gad, H., Kalderén, C., Koolmeister, T., Pham, T. M., Göktürk, C., Jafari, R., Maddalo, G., Seashore-Ludlow, B. A., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw429 · Cited by 138
“The use of cellular thermal shift assay (CETSA) combined with proteomics was recently described as a method to investigate how drug candidates can permeate and bind to targets within the cell [19, 20].”
MethodSelf-citationLysine-Targeted Inhibitors and Chemoproteomic Probes
Cuesta, A., & Taunton, J. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044805 · Cited by 149
“, cancer cell death), which kinases are occupied by the inhibitor and to what extent? Although selectivity is typically assessed by profiling a panel of purified recombinant kinases or kinase domains, recent chemoproteomic methods have been developed to interrogate hundreds of endogenously expressed kinases in a singl…”
BackgroundHigh throughput discovery of functional protein modifications by Hotspot Thermal Profiling
Huang, J., Lee, G., Cavanaugh, K. E., Chang, J. W., Gardel, M. L., & Moellering, R. E. (2019) · Nature Methods · doi:10.1038/s41592-019-0499-3 · Cited by 139
Dziekan, J. M., Wirjanata, G., Dai, L., Go, K. D., Yu, H., Lim, Y. T., Chen, L., Wang, L. C., Puspita, B., Prabhu, N., et al. (2020) · Nature Protocols · doi:10.1038/s41596-020-0310-z · Cited by 130
Self-citationChemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132
Self-citationSun, C., Zhou, J., Yu, Z., Huo, X., Zhang, J., Morisseau, C. H. P., Hammock, B. D., & Ma, X. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2118818119 · Cited by 139
Dai, L., Prabhu, N., Yu, L. Y., Bacanu, S., Ramos, A. D., & Nordlund, P. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012837 · Cited by 130
Self-citationPalanikumar, L., Karpauskaite, L., Al-Sayegh, M., Chehade, I., Alam, M., Hassan, S., Maity, D., Ali, L., Kalmouni, M., Hunashal, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23985-1 · Cited by 132
Beckham, K. S. H., Ciccarelli, L., Bunduc, C. M., Mertens, H. D. T., Ummels, R., Lugmayr, W., Mayr, J., Rettel, M., Savitski, M. M., Svergun, D. I., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.47 · Cited by 112
Self-citationCichońska, A., Ravikumar, B., Parri, E., Timonen, S., Pahikkala, T., Airola, A., Wennerberg, K., Rousu, J., & Aittokallio, T. A. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005678 · Cited by 127
“Recent technological advances in chemoproteomic approaches, such as thermal profiling [4], have enabled efficient determination of kinome-wide compound potency.”
BackgroundQuantitative Proteomics Using Isobaric Labeling: A Practical Guide
Chen, X.-L., Sun, Y., Zhang, T., Shu, L., Roepstorff, P., & Yang, F.-Q. (2021) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.012 · Cited by 107
“They combined the cellular thermal shift assay with the multiplexed isobaric tag-based quantitative proteomic method to achieve a proteome-wide determination of protein thermal stability by computing melting curves of proteins [157].”
BackgroundMethodInfluentialIn-Cell Structural Biology by NMR: The Benefits of the Atomic Scale
Theillet, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00937 · Cited by 131
Non-kinase targets of protein kinase inhibitors
Munoz, L. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.266 · Cited by 134
Advances in exploring the therapeutic potential of marine natural products
Liang, X., Luo, D., & Luesch, H. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104373 · Cited by 134
“[68,69] To study the effect of drugs on the thermal profile of proteins on a proteome-wide scale, thermal proteome profiling (TPP) was developed by combing CETSA with multiplexed quantitative mass spectrometry (Figure 6B).[70] TPP exhibits promising applicability in identifying both therapeutically relevant targets an…”
BackgroundMethodApplication of targeted mass spectrometry in bottom-up proteomics for systems biology research
Manes, N. P., & Nita‐Lazar, A. (2018) · Journal of Proteomics · doi:10.1016/j.jprot.2018.02.008 · Cited by 137
“In a related study, DDA LC-MS was used to globally measure differences in protein conformation across cancer drug treatments (targeted MS was not used) [88].”
MethodNeckers, L., Blagg, B. S. J., Haystead, T., Trepel, J. B., Whitesell, L. J., & Picard, D. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0877-2 · Cited by 123
The functional proteome landscape of Escherichia coli
Mateus, A., Hevler, J. F., Bobonis, J., Kurzawa, N., Shah, M., Mitosch, K., Goemans, C., Helm, D., Stein, F., Typas, A., et al. (2020) · Nature · doi:10.1038/s41586-020-3002-5 · Cited by 113
Self-citationSolvent-Induced Protein Precipitation for Drug Target Discovery on the Proteomic Scale
Zhang, X., Wang, Q., Li, Y., Ruan, C., Wang, S., Hu, L., & Ye, M. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b04531 · Cited by 119
A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase
Martinez, N. J., Asawa, R. R., Cyr, M. G., Zakharov, A. V., Urban, D. J., Roth, J. S., Wallgren, E., Klumpp-Thomas, C. A., Coussens, N. P., Rai, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-27834-y · Cited by 126
Decrypting drug actions and protein modifications by dose- and time-resolved proteomics
Zecha, J., Bayer, F. P., Wiechmann, S., Woortman, J., Berner, N., Müller, J., Schneider, A., Kramer, K., Abril-Gil, M., Hopf, T. A., et al. (2023) · Science · doi:10.1126/science.ade3925 · Cited by 127
Vartanian, S., Ma, T. P., Lee, J., Haverty, P. M., Kirkpatrick, D. S., Yu, K., & Stokoe, D. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.055509 · Cited by 123
“More recently, this assay was coupled with multiplexed mass spectrometry to yield an assay capable of surveying small molecule–protein interactions across a large fraction of the proteome (14).”
MethodWang, P., Joberty, G., Buist, A., Vanoosthuyse, A., Stancu, I., Vasconcelos, B., Pierrot, N., Faelth-Savitski, M., Kienlen‐Campard, P., Octave, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1663-9 · Cited by 123
“Proteome-wide screening approaches are increasingly used—in analogy to genomewide screening approaches—to gain novel insights from an unbiased starting point for drug discovery and fundamental science [3, 10, 27, 58, 62].”
BackgroundSelf-citation
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.